|
2024
|
Invention
|
Antibodies to programmed cell death protein 1 that are pd-1 agonists.
Antibodies and antigen-bin... |
|
|
Invention
|
Novel pd-l2 mutants. Isolated polypeptides are described, which are mutants of programmed cell de... |
|
|
Invention
|
Antibodies to programmed cell death protein 1 that are pd-1 agonists. Antibodies and antigen-bind... |
|
2022
|
Invention
|
Polypeptide modulators.
Isolated polypeptides are described, which are mutants of programmed dea... |
|
|
Invention
|
Polypeptide modulators. Isolated polypeptides are described, which are mutants of programmed deat... |
|
|
Invention
|
Akt3 modulators.
Compounds of Formula Ia or Ib are described, where the various substituents are... |
|
|
Invention
|
Akt3 modulators. in vitro or in vivoin vitro or in vivo, and can also be used, individually or in... |
|
2021
|
Invention
|
Akt3 modulators.
Compounds of Formula Ia, Ib, or Ic, Formula (Ia); Formula (Ib); or Formula (Ic)... |
